Literature DB >> 9008314

Unique HLA antigen frequencies in the Finnish population.

M K Sirén1, H Sareneva, M L Lokki, S Koskimies.   

Abstract

The Finnish Bone Marrow Donor Registry was established 1992 to serve Finnish patients in urgent need of bone marrow transplantation. This study details the HLA antigen frequencies, including those of the A 19 subtypes, in the Finnish population. Large regional variations were found in antigen frequencies between the different geographical areas of Finland. In particular, antigens A9, B12, B35, Cw4 and DR3 display regional frequency deviations, but B7, B8 and B15 also exhibit regional variations. The present population is the largest (n = 10,000) ever HLA-typed in Finland. 97% of the donors were HLA-A-B-DR typed. Confirmation of the serological HLA type was performed by DNA typing on 3% of the donors in the registry. A potential donor was found for 52% of Finnish patients in need of a matched unrelated donor for a bone marrow transplantation. Due to the ethnic origin of the Finns, it is not easy to find suitable bone marrow donors for Finnish patients in worldwide registries. It is thus important to maintain a national bone marrow donor registry which recruits donors from all over the country.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9008314     DOI: 10.1111/j.1399-0039.1996.tb02695.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  7 in total

1.  Subpopulation difference scanning: a strategy for exclusion mapping of susceptibility genes.

Authors:  E Salmela; O Taskinen; J K Seppänen; P Sistonen; M J Daly; P Lahermo; M-L Savontaus; J Kere
Journal:  J Med Genet       Date:  2006-01-27       Impact factor: 6.318

2.  Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses.

Authors:  M-L Sumelahti; P J Tienari; M Hakama; J Wikström
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

3.  Regional differences in the incidence of rheumatoid arthritis in Finland in 1995.

Authors:  O Kaipiainen-Seppänen; K Aho; M Nikkarinen
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

4.  Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis.

Authors:  E Jaakkola; I Herzberg; K Laiho; M C N M Barnardo; J J Pointon; M Kauppi; K Kaarela; E Tuomilehto-Wolf; J Tuomilehto; B P Wordsworth; M A Brown
Journal:  Ann Rheum Dis       Date:  2005-10-25       Impact factor: 19.103

5.  Association of Chlamydia pneumoniae infection with HLA-B*35 in patients with coronary artery disease.

Authors:  Anil Palikhe; Marja-Liisa Lokki; Pekka Saikku; Maija Leinonen; Mika Paldanius; Mikko Seppänen; Ville Valtonen; Markku S Nieminen; Juha Sinisalo
Journal:  Clin Vaccine Immunol       Date:  2007-11-07

6.  Blood donor biobank and HLA imputation as a resource for HLA homozygous cells for therapeutic and research use.

Authors:  Jonna Clancy; Kati Hyvärinen; Jarmo Ritari; Tiina Wahlfors; Jukka Partanen; Satu Koskela
Journal:  Stem Cell Res Ther       Date:  2022-10-09       Impact factor: 8.079

7.  Diversity of extended HLA-DRB1 haplotypes in the Finnish population.

Authors:  Annika Wennerström; Efthymia Vlachopoulou; L Elisa Lahtela; Riitta Paakkanen; Katja T Eronen; Mikko Seppänen; Marja-Liisa Lokki
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.